The current research and development of global biomedicine has begun to enter the bottleneck period，The average R & D cost of an innovative drug is about $ 1.5 billion，It takes more than 10 years to spend more than 10 years，And these numbers are still rising，But the number of new drug development has decreased sharply。plus the financial crisis，Many pharmaceutical giants have begun to put the cost reduction in the first place，To save expenses、stake sports betting appHigh profit，Biotechnology My stake betting appoutsourcing (CRO) becomes an important way，The global market is growing at a rate of 30%per year。

   Because China's labor cost is only equivalent to 1/10，Therefore, the transfer of biotechnology outsourcing to China is the general trend。It is reported，2008 China's pharmaceutical research and development outsourcing market is about 260 million US dollars，It is expected to increase to US $ 430 million by 2010，annual growth rate is as high as 40%。At present, there are hundreds of biotechnology outsourcing companies nationwide。Among them, companies engaged in new drugs are screened by the majority of compounds，The competition is very stake sports betting appintense，Large companies stake sports betting appstake sports bettingwith a size of thousands of people。But there are not many companies engaged in animal tests and clinical trials，Still in the bud stage。